Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sacre

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Drug Targets|September 1, 2009
Targeting Toll-like receptors in autoimmunityK S Midwood, A M Piccinini, S Sacre
Journal of Biological Regulators and Homeostatic Agents|March 16, 2013
Erythropoietin does not affect TNF and IL-6 production directlyI Cervellini, S Sacre, P Ghezzi, et al.
Geriatric Nursing (New York, N.Y.)|April 28, 2001
Audio presence intervention for decreasing agitation in people with dementiaS Miller, P E Vermeersch, K Bohan, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?M Feldmann, E Andreakos, C Smith, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Drug Targets|September 1, 2009
Targeting Toll-like receptors in autoimmunityK S Midwood, A M Piccinini, S Sacre
Journal of Biological Regulators and Homeostatic Agents|March 16, 2013
Erythropoietin does not affect TNF and IL-6 production directlyI Cervellini, S Sacre, P Ghezzi, et al.
Geriatric Nursing (New York, N.Y.)|April 28, 2001
Audio presence intervention for decreasing agitation in people with dementiaS Miller, P E Vermeersch, K Bohan, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?M Feldmann, E Andreakos, C Smith, et al.
Pageof 1